Project Details
Description
Testing Selective ROCK2 Inhibitor GB101 in Acute Grave-versus-Host Disease in Mice
Status | Finished |
---|---|
Effective start/end date | 1/28/21 → 12/31/21 |
Funding
- EQUILIBRE BIOPHARMACEUTICALS CORP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.